Pharmaceutical Lethal Service Catalytic Reactors
Pharmaceutical Lethal Service Catalytic Reactors from Roben Manufacturing enable safe processing of highly potent active pharmaceutical ingredients and toxic intermediates. Our reactors combine pharmaceutical-grade construction with the rigorous safety features required for lethal service in drug manufacturing.
What Are Pharmaceutical Lethal Service Catalytic Reactors?
Pharmaceutical Lethal Service Catalytic Reactors are designed for the unique requirements of drug manufacturing where catalytic processes involve highly toxic compounds, potent APIs, or hazardous intermediates. These reactors provide pharmaceutical-grade surfaces and cleanability while maintaining complete containment of lethal materials.
Why Choose Roben Pharmaceutical Lethal Service Catalytic Reactors?
- Pharmaceutical-grade surface finishes for cleanability
- Complete containment of highly potent compounds
- cGMP-compatible design and documentation
- Validated cleaning and sterilization capability
- Batch documentation supporting regulatory compliance
Key Features and Capabilities
- Electropolished product contact surfaces (Ra < 0.5 μm available)
- Contained catalyst charging and discharge systems
- CIP/SIP compatible design features
- Isolator and glove box integration options
- Full material and fabrication documentation packages
Applications
- Catalytic hydrogenation of pharmaceutical intermediates
- API synthesis involving potent or toxic compounds
- Chiral catalyst processes for enantiomer production
- Cytotoxic compound processing
Compliance and Certifications
Our Pharmaceutical Lethal Service Catalytic Reactors meet rigorous industry standards including ASME Section VIII Division 1 with mandatory lethal service provisions (100% RT on all butt welds, impact testing per UG-84), ISO 9001:2015 quality management certification, API standards for petroleum industry applications, and NACE MR0175/ISO 15156 for sour service when applicable. Each reactor receives U-stamp certification with National Board registration and complete documentation supporting regulatory approval.
Quality Assurance for Lethal Service
Every lethal service reactor undergoes enhanced quality verification: 100% radiographic testing of all pressure-containing welds, positive material identification (PMI) of all pressure parts, hydrostatic testing per ASME requirements, leak testing of all mechanical joints, and complete documentation with full material traceability. Our lethal service quality program exceeds standard pressure vessel requirements to ensure absolute containment integrity.
Frequently Asked Questions
Q: How do pharmaceutical lethal service reactors meet cGMP requirements?
A: We design reactors with smooth, cleanable surfaces, proper drainability, documented materials, and features supporting validated cleaning procedures. Complete fabrication documentation supports equipment qualification and regulatory inspections.
Q: What containment levels are available for pharmaceutical reactors?
A: We design for OEB (Occupational Exposure Band) requirements from OEB 3 through OEB 5 for the most potent compounds. Containment features include sealed systems, contained sampling, and integration with isolators or restricted access barriers.
Q: Can reactors be validated for pharmaceutical production?
A: Yes, we provide documentation supporting IQ/OQ validation protocols, including certified materials, dimensional verification, surface finish measurement, and pressure testing records. Design features facilitate cleaning validation and ongoing compliance.
Contact Roben Manufacturing
Ready to discuss your pharmaceutical lethal service catalytic reactors requirements? Contact Roben Manufacturing for expert consultation on lethal service catalytic reactor solutions. Our engineering team will work with you to develop the optimal reactor design for your specific application, materials, and safety requirements.
Phone: (281) 441-4088
Email: info@robenmfg.com
Website: www.robenmfg.com
